Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Dominique Spaëth. (2008) Epoetin beta once weekly: review of its efficacy and safety in patients with chemotherapy-induced anemia. Expert Review of Anticancer Therapy 8:6, pages 875-885.
Read now
Read now
Paul Cornes, Bertrand Coiffier & Jean-Jacques Zambrowski. (2007) Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option. Current Medical Research and Opinion 23:2, pages 357-368.
Read now
Read now
Tim Littlewood, Jean-Jacques Zambrowski & Paul Cornes. (2006) Treating anaemia: deconstructing healthcare costs. Current Medical Research and Opinion 22:sup4, pages S23-S33.
Read now
Read now
Samir Agrawal, Neville Davidson, Mel Walker, Sian Gibson, Christina Lim, Christopher Ll. Morgan & Warren Cowell. (2006) Assessing the total costs of blood delivery to hospital oncology and haematology patients. Current Medical Research and Opinion 22:10, pages 1903-1909.
Read now
Read now
Articles from other publishers (7)
Thomas A. Lane. 2011. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures
381
405
.
Andrew Lloyd, Patricia van Hanswijck de Jonge, Scott Doyle & Paul Cornes. (2008) Health State Utility Scores for Cancer-Related Anemia through Societal and Patient Valuations. Value in Health 11:7, pages 1178-1185.
Crossref
Crossref
P. HERAS, K. KRITIKOS, A. HATZOPOULOS & D. MITSIBOUNAS. (2008) Once-weekly epoetin beta therapy in patients with solid tumours and chemotherapy-induced anaemia: a randomized, double-blind, dose-finding study. European Journal of Cancer Care.
Crossref
Crossref
Paul Cornes. 2008. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
813
849
.
Caroline Hastings & James Feusner. 2008. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
635
661
.
Mohammad Resa Nowrousian. (2006) Regarding “Randomized Comparison of Epoetin Alfa and Darbepoetin Alfa in Anemic Patients with Cancer Receiving Chemotherapy”. The Oncologist 11:5, pages 535-536.
Crossref
Crossref
Roberto Stasi, Sergio Amadori, Adrian C. Newland & Drew Provan. (2004) Comparison of rHuEpo plus rHuG-CSF and supportive care: apples to oranges. Blood 104:7, pages 2201-2202.
Crossref
Crossref